Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial

Authors

Victor J. Navarro, Einstein Medical Center and Sidney Kimmel Medical College
Steven H. Belle, University of Pittsburgh
Massimo D'Amato, Rottapharm Biotech, Monza MB
Nezam Adfhal, Beth- Israel Deaconess Medical Center, Boston
Elizabeth M. Brunt, Washington University School of Medicine in St. Louis
Michael W. Fried, University of North Carolina at Chapel Hill
K. Rajender Reddy, University of Pennsylvania
Abdus S. Wahed, University of Pittsburgh
Stephen Harrison, Brooke Army Medical Center, Fort Sam Houston
Silymarin in NASH and C Hepatitis (SyNCH) Study Group

Journal

PLoS One

Publication Date

1-1-2019

Volume

14

Issue

9

First Page

e0221683

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0221683

Rights and Permissions

Navarro VJ, Belle SH, D’Amato M, Adfhal N, Brunt EM, et al. (2019) Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial. PLOS ONE 14(9): e0221683. https://doi.org/10.1371/journal.pone.0221683

Recommended Citation

Navarro, Victor J.; Belle, Steven H.; D'Amato, Massimo; Adfhal, Nezam; Brunt, Elizabeth M.; Fried, Michael W.; Reddy, K. Rajender; Wahed, Abdus S.; Harrison, Stephen; and Silymarin in NASH and C Hepatitis (SyNCH) Study Group, "Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial." PLoS One. 14, 9. e0221683 (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8661